Nicole Labor
Addiction Medicine · Akron, OHNPI 1598908485
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $12,887 of the $17,167 with a category attached, or 75.1%. Indivior Inc. accounts for 87.2% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $15,985, more than ten times the $150 reported in 2019. Among addiction medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 146 payments — averaging $117.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Indivior Inc.$15K
- Braeburn Inc.$880
- Orexo US, Inc.$360
- Alkermes, Inc.$223
- Revance Therapeutics, Inc.$199
- Merz North America, Inc.$129
- plus $413 from 9 others
Across 1 payment — averaging $150.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Indivior Inc.$150
What the payments were for
- Speaking & faculty fees$12,88775%
- Travel & lodging$1,1417%
- Food & beverage$3,13718%
- Education$20%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Indivior Inc. | 76 | $14,962 |
| Braeburn Inc. | 10 | $880 |
| Orexo US, Inc. | 22 | $360 |
| Alkermes, Inc. | 12 | $223 |
| Revance Therapeutics, Inc. | 4 | $199 |
| Merz North America, Inc. | 2 | $129 |
| AbbVie | 6 | $127 |
| Gilead | 5 | $106 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $40 |
| Lundbeck LLC | 2 | $39 |
| Merck | 1 | $25 |
| Luye Pharma (USA) Ltd. | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| MDD US Operations, LLC | 1 | $17 |
| USWM, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,167 in reported general payments places this provider in the 95th percentile of 98 addiction medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrixadiBuprenorphine | 16 | $24,825 |
| VivitrolNaltrexone Microspheres | 12 | $20,291 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 80 | $12,768 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 28 | $11,776 |
| MresviaRsv Vaccine, Pref, Mrna/Pf | 33 | $10,560 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $8,699 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 20 | $6,498 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 11 | $2,458 |
| Ibuprofen | 20 | $304 |
| Gabapentin | 11 | $303 |
| Atorvastatin Calcium | 14 | $265 |
| Lisinopril | 20 | $258 |
| Amlodipine Besylate | 14 | $116 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Braeburn Inc.Brixadi | $880 | $24,82516 claims |
| Alkermes, Inc.Vivitrol | $223 | $20,29112 claims |
| Orexo US, Inc.Zubsolv | $360 | $11,77628 claims |
| Indivior Inc.Suboxone | $14,962 | $8,69911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 98 addiction medicine providers in Ohio.
Other addiction medicine in Akron
- William GoldmanAkron$407
- Gregory JohnsonAkron$217
- Parag PatelCincinnati$171K
- Stephanie TraylorColumbus$86K
- Wayne KawalekOakwood Village$82K
- Orman HallColumbus$10K
- Puja SrivastavaWilmington$9K
- David KesegChillicothe$8K
- Timothy SuttonMansfield$6K
- Robert MasoneColumbus$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.